The antihyperlipidemic effects of fullerenol nanoparticles via adjusting the gut microbiota in vivo.

Juan LiRunhong LeiXin LiFengxia XiongQuanyang ZhangYue ZhouShengmei YangYanan ChangKui ChenWeihong GuChongming WuGengmei Xing

Published in: Particle and fibre toxicology (2018)

The two fullerenol NPs remarkably modulate the gut microbiota and selectively enrich SCFA-producing bacteria, which may be an important reason for their anti-hyperlipidemic effect in mice.

Keyphrases

high fat diet induced
type diabetes
metabolic syndrome
insulin resistance
adipose tissue
wild type
oxide nanoparticles
walled carbon nanotubes